Probiotics, bile acids and gastrointestinal carcinogenesis
- PMID: 29512647
- PMCID: PMC5898972
- DOI: 10.1038/nrgastro.2018.24
Probiotics, bile acids and gastrointestinal carcinogenesis
Conflict of interest statement
The authors declare no competing interests.
Comment on
-
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):111-128. doi: 10.1038/nrgastro.2017.119. Epub 2017 Oct 11. Nat Rev Gastroenterol Hepatol. 2018. PMID: 29018272 Free PMC article. Review.
-
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis: a role for bifidobacteria and lactobacilli?Nat Rev Gastroenterol Hepatol. 2018 Apr;15(4):205. doi: 10.1038/nrgastro.2018.23. Epub 2018 Mar 7. Nat Rev Gastroenterol Hepatol. 2018. PMID: 29512648 No abstract available.
References
-
- Sánchez B. Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis: a role for bifidobacteria and lactobacilli? Nat Rev Gastroenterol Hepatol - PubMed
-
- Kurdi P, et al. Cholic acid accumulation and its diminution by short-chain fatty acids in bifidobacteria. Microbiology. 2003;149:2031–2037. - PubMed
-
- Guo CF, et al. Screening for cholesterol-lowering probiotic based on deoxycholic acid removal pathway and studying its functional mechanisms in vitro. Anaerobe. 2012;18:516–522. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
